VasDeBlock announces issuance of US patent

[...]“We are pleased to have secured the patent for our non-hormonal, non-surgical, easily reversible contraceptive allowing men to participate in the family planning” said Mette Mikkelsen, CEO of VasDeBlock. “This latest patent approval is an important step in our development of long-acting, reversible male contraception”.

VasDeBlock CEO selected for the Tech Nordic Advocates Women in tech programme

VasDeBlock in Tech Nordic Advocates 2021

CEO Mette Mikkelsen selected for the WOMEN IN TECH programme.

VasDeBlock selected among 10 Nordic HealthTech finalists

VasDeBlock wins "Most promising investment pitch"

Selected among ten pitches at NORDIC HEALTHTECH TALENTS demo day 12 April 2019.

Alexander Foss grant

VasDeBlock receives Alexander Foss grant 2018

We are proud to be awarded by Alexander Foss' Industrifond at EY Entrepreneur of the Year event in Forum, Copenhagen

VasDeBlock in Venture Cup Denmark 2018

Selected for the NORDIC HEALTHTECH TALENTS program

VasDeBlock in Scale-Up Denmark 2017

Made it to the finals after an intensive training program

techsavvy giver bud på fremtidens hospitalsdimser

VasDeBlock at Medico Bazar 2017

TechSavvy predict to see VasDeBlock in future hospital settings...

VasDeBlock in MEDWATCH articles

Press coverage in the Danish medtech & pharma media

inventor Niel Lindeburg is interviewed for Danish tv TV2 Nyhederne

VasDeBlock at Danish Tech Challenge 2015

Inventor Niels Lindeburg is interviewed by TV2 Nyhederne (in Danish)

a Danish electrician came up with a good idea

The idea of a Danish electrician

A tube - like vas deferens - can be plugged and later unplugged. That's the idea that electrician Niels Lindeburg came up with

VasDeBlock medical ApS
Storkevaenget 8
DK-4653 Karise

Email: contact@vasdeblock.com
Phone: +45 51372969
VAT: DK-37525758

Copyright (c) 2021 VasDeBlock medical ApS

Thanks for reaching out!